Hello, Fool! | Login | Signup | My Fool
Oct 7, 2008 6:51 AM ET | Feedback | Site Changes | Help
A biopharmaceutical company which advances oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers.
View All Commentary (IMCL)
Recs
MattCraig (32.68) Submitted: 7/21/08 8:22 AM : Start Price: $46.97 IMCL Score: 35.33
will takeover focus sweep group after DNA?
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK